A Job Well Done: AstraZeneca Bids Adieu To Vaxzevria As Demand Dries Up

The voluntary withdrawal of the license for the UK major's COVID-19 vaccine is due to a surplus of available updated jabs from other companies that target new variants and is not connected to the mis- and disinformation being peddled on the internet and elsewhere on very rare adverse events.